This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm of other and unspecified sites (controls excluding all cancers)
CD2_BENIGN_OTHER_NOS_EXALLC
No definition available.
Endpoint definition
↥
FinnGen phenotype data
individuals
Apply sex-specific rule None
Check conditions None
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Remove individuals based on genotype QC
938
CD2_BENIGN_OTHER_NOS_EXALLC
Control definitions
Control exclude
C3_CANCER
Extra metadata
Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D10-D36
Name in latin
Neoplasmata benigna locis aliis et non specificatis
No upset plot: script not run.
No upset table: script not run.
Similar endpoints
↥List of similar endpoints to
Benign neoplasm of other and unspecified sites (controls excluding all cancers)
based on the number of shared cases.
Broader endpoints:
- Benign neoplasm of other and unspecified sites
- Benign neoplasms
- Benign neoplasms (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Narrower endpoints:
- Benign neoplasm of other and unspecified sites
- Benign neoplasm: Other/unspecified site
- Benign neoplasm: Other/unspecified site (controls excluding all cancers)
- Benign neoplasm: Peripheral nerves and autonomic nervous system
- Benign neoplasm: Peripheral nerves and autonomic nervous system (controls excluding all cancers)
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 938 | 530 | 408 |
| Unadjusted prevalence (%) | 0.23 | 0.23 | 0.22 |
| Mean age at first event (years) | 47.66 | 45.74 | 50.15 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_BENIGN_OTHER_NOS_EXALLC – Benign neoplasm of other and unspecified sites (controls excluding all cancers)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Benign neoplasm of other and unspecified sites (controls excluding all cancers)
↥Endpoint not on priority list, no data to show.